Abbreviations
15(OH)D | 25-hydroxy vitamin D |
aBMD | areal bone mineral density |
AIS | American Spinal Injury Association Impairment Scale |
ALP | alkaline phosphatase |
BALP | bone-specific alkaline phosphatase |
BMC | bone mineral content |
BMD | bone mineral density |
BMI | body mass index |
CI | confidence interval |
CINP | C-terminal propeptide of type I collagen |
CT | computed tomography |
CTX | Type I collagen C-telopeptide |
CV | coefficient of variation |
DPA | dual-energy photon absorptiometry |
DPD | deoxypyridinoline |
DXA | dual-energy-X-ray absorptiometry |
FES | functional electrical stimulation |
HR | hazard ratio |
HR-pQCT | High-resolution peripheral quantitative computed tomography |
IFCC-IOF | International Osteoporosis Foundation and the International Federation of Clinical Chemistry and Laboratory Medicine |
ISCD | International Society for Clinical Densitometry |
LSC | least significant change |
MCID | minimal clinically important difference |
MRI | magnetic resonance imaging |
NBHA | National Bone Health Alliance |
NMES | neuromuscular electrical stimulation |
NTX | N-telopeptide |
OC | osteocalcin |
OR | odds ratio |
P1NP | procollagen Type I N propeptide obtained from serum |
pQCT | peripheral quantitative computed tomography |
RCT | Randomized controlled trial |
SCI | Spinal Cord Injury |
SD | standard deviation |
SLOP | sublesional osteoporosis |
TPI | time post-injury |
TNF | tumour necreosis factor α |
vBMD | volumetric bone mineral density |
Chapter Downloads
Patient Handouts
Toolkits
Videos
Active Clinical Trials